Mavoglurant in Fragile X Syndrome: Results of Two Open-Label, Extension Trials in Adults and Adolescents
Scientific Reports - United Kingdom
doi 10.1038/s41598-018-34978-4
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 19, 2018
Authors
Publisher
Springer Science and Business Media LLC